Table 5.
Annual average drug costs per patient for different antihypertensives according to the pattern of persistence [23]
Antihypertensive |
Continuers [95%CI] |
Switchers [95%CI] |
Discontinuers 95%CI] |
Total [95%CI] |
Diuretics | € 65.09 [58.67–71.52] |
€ 153.10 [137.59–168.62] |
€ 8.17 [7.60–8.75] |
€ 33.45 [30.97–35.93] |
Beta-blockers | € 109.29 [102.46–116.12] |
€ 158.73 [139.61–177.84] |
€ 22.52 [24.24-23.79] |
€ 63.40 [59.94–66.86] |
Calcium-channel blockers | € 234.63 [224.78–244.47] |
€ 199.62 [183.45–215.78] |
€ 38.24 [36.78–39.70] |
€ 104.43 [100.07–108.79] |
ACE inhibitors | € 196.28 [189.69–202.86] |
€ 237.53 [222.28–252.79] |
€ 34.76 [33.53–35.99] |
€ 108.25 [104.43–112.09] |
Angiotensin II antagonists | € 326.16 [313.05–339.27] |
€ 268.07 [241.55–294.39] |
€ 67.10 [62.89–71.31] |
€ 201.53 [191.24–211.81] |
Total |
€ 171.73 [167.43–176.04] |
€ 205.10 [196.85–213.34] |
€ 28.29 [27.62–28.97] |
€ 88.09 [86.10–90.08] |
CI, confidence interval